Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors.

Brockenbrough JS, Souquet T, Morihara JK, Stern JE, Hawes SE, Rasey JS, Leblond A, Wiens LW, Feng Q, Grierson J, Vesselle H.

J Nucl Med. 2011 Aug;52(8):1181-8. doi: 10.2967/jnumed.111.089482. Epub 2011 Jul 15.

PMID:
21764789
[PubMed - indexed for MEDLINE]
Free Article
2.

DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.

Hawes SE, Stern JE, Feng Q, Wiens LW, Rasey JS, Lu H, Kiviat NB, Vesselle H.

Lung Cancer. 2010 Aug;69(2):172-9. doi: 10.1016/j.lungcan.2009.11.002. Epub 2009 Nov 28.

PMID:
19945765
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.

Brockenbrough JS, Morihara JK, Hawes SE, Stern JE, Rasey JS, Wiens LW, Feng Q, Vesselle H.

J Histochem Cytochem. 2009 Nov;57(11):1087-97. doi: 10.1369/jhc.2009.952804. Epub 2009 Aug 3.

PMID:
19654105
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A simple quantitative assay for the activity of thymidine kinase 1 in solid tumors.

Brockenbrough JS, Rasey JS, Grierson JR, Wiens LW, Vesselle H.

Nucl Med Biol. 2007 Aug;34(6):619-23.

PMID:
17707801
[PubMed - indexed for MEDLINE]
6.

Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity.

Grierson JR, Brockenbrough JS, Rasey JS, Wiens LW, Schwartz JL, Jordan R, Vesselle H.

Nucl Med Biol. 2007 Jul;34(5):471-8. Epub 2007 May 11.

PMID:
17591546
[PubMed - indexed for MEDLINE]
7.

Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

Rasey JS, Grierson JR, Wiens LW, Kolb PD, Schwartz JL.

J Nucl Med. 2002 Sep;43(9):1210-7.

PMID:
12215561
[PubMed - indexed for MEDLINE]
Free Article
8.

Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines.

Russell KJ, Wiens LW, Demers GW, Galloway DA, Le T, Rice GC, Bianco JA, Singer JW, Groudine M.

Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1099-106.

PMID:
8985032
[PubMed - indexed for MEDLINE]
9.

Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.

Russell KJ, Wiens LW, Demers GW, Galloway DA, Plon SE, Groudine M.

Cancer Res. 1995 Apr 15;55(8):1639-42.

PMID:
7712467
[PubMed - indexed for MEDLINE]
Free Article
10.

Inhibition of radiation cataractogenesis by WR-77913.

Livesey JC, Wiens LW, Von Seggern DJ, Barlow WE, Arnold AM.

Radiat Res. 1995 Jan;141(1):99-104.

PMID:
7997522
[PubMed - indexed for MEDLINE]
11.

Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy.

Russell KJ, Dunatov C, Hafermann MD, Griffeth JT, Polissar L, Pelton J, Cole SB, Taylor EW, Wiens LW, Koh WJ, et al.

J Urol. 1991 Oct;146(4):1046-52.

PMID:
1716696
[PubMed - indexed for MEDLINE]
12.

Transient and chronic neurological complications of fast neutron radiation for adenocarcinoma of the prostate.

Russell KJ, Laramore GE, Krieger JN, Wiens LW, Griffeth JT, Koh WJ, Griffin BR, Austin-Seymour MM, Griffin TW, Davis LW.

Radiother Oncol. 1990 Jul;18(3):257-65.

PMID:
2120742
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk